Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
InnoCare today announced that tafasitamab in combination with lenalidomide has been recently approved by the Medical Products Administration of Guangdong Province under the early access
Prilenia Therapeutics BV a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders
Tempus a leader in artificial intelligence and precision medicine today announced the addition of a novel MRD assay xM to its comprehensive testing solutions The tumornave plasma based test
EGenesis a biotechnology company developing humancompatible organs and cells for the treatment of organ failure and OrganOx a medical device company with a focus on the therapeutic applications of isolated organ perfusion
Helio Genomics an AIdriven healthcare company specializing in diagnostics technology and test development for cancer detection today announced that results from an important new research study have been published in the peerreviewed journal
Biomica Ltd a clinicalstage biopharmaceutical company developing innovative microbiomebased therapeutics and a subsidiary of Evogene Ltd today announced that the final patient has been enrolled in its Phase I clinical trial
WuXi Biologics a leading global Contract Research Development and Manufacturing Organization today announced that a patent for WuXiBodyTM a proprietary
Sun Pharmaceutical Industries Limited and Bayer today announced that both companies have signed an agreement to market and distribute a second brand of Finerenone in India Finerenone a patented medicine is indicated
Kairos Pharma Ltd a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse cancer drug resistance and immune suppression announces the dosing of its first two patients in its Phase trial
Delcath Systems Inc an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver today announced the first commercial use of HEPZATO KIT for the treatment of metastatic uveal melanoma
